Citation Impact
Citing Papers
Subcutaneous Adjusted-Dose Unfractionated Heparin vs Fixed-Dose Low-Molecular-Weight Heparin in the Initial Treatment of Venous Thromboembolism
2004
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII
2008
Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta‐analysis
2014
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Aspirin for Preventing the Recurrence of Venous Thromboembolism
2012
A Population-Based Study of the Effectiveness of Inferior Vena Cava Filter Use Among Patients With Venous Thromboembolism
2000
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
1996
Individually tailored duration of elastic compression therapy in relation to incidence of the postthrombotic syndrome
2010
A conceptual framework for two phases of anticoagulant treatment of venous thromboembolism
2012
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Pulmonary Embolism
1998
Diabetes as a risk factor for myocardial infarction: population and gender perspectives
1997
Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism
2000
Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study
2012
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study
2002
Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rate
1997
Inflammation and metabolic disorders
2006 StandoutNature
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
2003
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
1997
Recurrent Venous Thromboembolism After Deep Vein Thrombosis
2000
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*
2003 Standout
The controversy of managing calf vein thrombosis
2011
Prognosis of Cancers Associated with Venous Thromboembolism
2000 Standout
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
2004 StandoutNature
Predictors of Recurrence After Deep Vein Thrombosis and Pulmonary Embolism
2000 Standout
Risk of Recurrent Venous Thromboembolism in Patients With Common Thrombophilia
2006
The metabolic syndrome
2010 Standout
Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor
2010
Antithrombotic Therapy for VTE Disease
2016 Standout
Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy
2010
Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study
1997
The role of vena caval filters in the management of venous thromboembolism
2004
Insulin‐based regimens decrease mortality rates in critically ill patients: a systematic review
2006
How does blood glucose control with insulin save lives in intensive care?
2004
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats
2006
Prognostic Value of ECG Among Patients with Acute Pulmonary Embolism and Normal Blood Pressure
2009
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
2013
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Unresolved issues in anticoagulant therapy
2003
G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism
2001
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
2008
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
1998 Standout
Management of Hyperglycemia in the Hospital Setting
2006
Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D)
2005
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis
2010
Severe Hypoglycemia Monitoring and Risk Management Procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Deep-vein thrombosis
1999
Treatment of Deep-Vein Thrombosis
2004
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
2011
Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
2013
Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention
2014
The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus
2001
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
2006
Antithrombotic Therapy for VTE Disease
2012 Standout
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
Platelet Activation and Atherothrombosis
2007 Standout
The metabolic syndrome
2005 Standout
Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
2012
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials
2011
2006
The risk of recurrent venous thromboembolism: The Austrian Study on Recurrent Venous Thromboembolism
2003
Symptomatic Pulmonary Embolism and the Risk of Recurrent Venous Thromboembolism
2004
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Hydrocortisone Therapy for Patients with Septic Shock
2008 Standout
Gut metagenome in European women with normal, impaired and diabetic glucose control
2013 StandoutNature
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study
2003
D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis
2005
Stress-Induced Hyperglycemia
2001
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis
2006
The Effects of Improved Glycemic Control on Complications in Type 2 Diabetes
1998
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
D-Dimer Levels and Risk of Recurrent Venous Thromboembolism
2003
Pulmonary thromboembolic disease spectrum: diagnostic and therapeutic strategies
2009
The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event
2003
Myocardial Reperfusion Injury
2007 Standout
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
2011
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study
2009
The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment
2015
HOSPITAL MANAGEMENT OF DIABETES
2000
The Pathophysiology and Treatment of Sepsis
2003 Standout
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
2003
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
2007
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran
2003
Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis
2001
Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy
1998
The post-thrombotic syndrome: current knowledge, controversies, and directions for future research
2002
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
The Risk of Recurrent Venous Thromboembolism in Men and Women
2004
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial
2007
Ultrasound-accelerated Thrombolysis for the Treatment of Deep Vein Thrombosis: Initial Clinical Experience
2008
Deep-Vein Thrombosis of the Upper Extremities
2011
Proinflammatory Effects of Glucose and Anti-Inflammatory Effect of Insulin: Relevance to Cardiovascular Disease
2006
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism
1998
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Prevention of Venous Thromboembolism
1998
Hemorrhagic Complications of Anticoagulant Treatment
2004
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Management of Venous Thromboembolism
1996
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Use of Statins and the Subsequent Development of Deep Vein Thrombosis
2001
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Management of Anticoagulation before and after Elective Surgery
1997
Intensive Insulin Therapy in the Medical ICU
2006 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
2009
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy
2000
Management of Diabetes and Hyperglycemia in Hospitals
2004
Estudio multicéntrico, prospectivo, de comparación del tratamiento de la tromboembolia pulmonar submasiva con enoxaparina y heparina no fraccionada
2003
Venous Thromboembolism
1999
Glucose-Insulin-Potassium Therapy for Treatment of Acute Myocardial Infarction
1997
Impact of Diabetes on Mortality After the First Myocardial Infarction
1998
Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism
2010
Glucose Potassium Insulin Infusions in the Treatment of Acute Stroke Patients With Mild to Moderate Hyperglycemia
1999
Comparative Outcomes of Catheter-Directed Thrombolysis Plus Anticoagulation vs Anticoagulation Alone to Treat Lower-Extremity Proximal Deep Vein Thrombosis
2014
The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in Patients with the G20210A Transition in the Prothrombin Gene
1999
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis
2000
Vena caval filters: a comprehensive review
2000
Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism
2003
Thrombolysis for acute deep vein thrombosis
2016
Incidence of Idiopathic Deep Venous Thrombosis and Secondary Thromboembolism among Ethnic Groups in California
1998
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies
2014
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
2004 Standout
Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events
2005
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
2005
Insulin Therapy for Critically Ill Hospitalized Patients
2004
Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options
2010
Type 2-diabetes og det metaboliske syndrom - diagnostik og behandling
2000
Natural History of Venous Thromboembolism
2003
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction
2005
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
2003
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial
2008
Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion
2004
Low Molecular Weight Heparin versus Acenocoumarol in the Secondary Prophylaxis of Deep Vein Thrombosis
1999
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism
1995
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
2003
Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis
2009
The Need for Glycemic Trials in Type 2 Diabetes
2003
Systematic Review: d -Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism
2008
Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism
2008
Warfarin therapy: evolving strategies in anticoagulation.
1999
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
Extended Prophylaxis of Venous Thromboembolism with Idraparinux
2007
TARGETED CONTRAST AGENTS IN MR IMAGING
1996
The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism
2007
Low Molecular Weight Heparin (Enoxaparin) Versus Oral Anticoagulant Therapy (Acenocoumarol) in the Long-Term Treatment of Deep Venous Thrombosis in the Elderly: a Randomized Trial
2000
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The Epidemiology of Venous Thromboembolism in the Community: Implications for Prevention and Management
2006
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study
2008
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis
2006
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism
2002
Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction
1999
Predictive Value of D-Dimer Test for Recurrent Venous Thromboembolism After Anticoagulation Withdrawal in Subjects With a Previous Idiopathic Event and in Carriers of Congenital Thrombophilia
2003
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
2014
Risk of Venous Thromboembolism Recurrence: High Negative Predictive Value of D-dimer Performed after Oral Anticoagulation Is Stopped
2002
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
2012 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
1998
Surface molecular recognition
2001 StandoutNobel
Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism
2010
Comparison of 3 and 6 Months of Oral Anticoagulant Therapy After a First Episode of Proximal Deep Vein Thrombosis or Pulmonary Embolism and Comparison of 6 and 12 Weeks of Therapy After Isolated Calf Deep Vein Thrombosis
2001
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
2005
How I treat isolated distal deep vein thrombosis (IDDVT)
2014
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
2013
Works of Peter Nicol being referenced
Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months
2006
A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism
1995
The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism
1997
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
1995 Standout
Evaluation of myocardial infarct size before and after reperfusion: dual-tracer imaging with radiolabeled antimyosin antibody.
1994
A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism
1996